Now more than ever, the world is focused on in vitro diagnostic tests. But what is the market opportunity for those currently selling test products and new entrants. Where has COVID-19 impacted IVD testing positively and negatively? Was is the impact of the pandemic and the recovery from the pandemic on other IVD test categories.
This webinar is a sneak peak into this insightful Kalorama Information report. Kalorama Publisher and Science and Medicine Group Senior Vice President Bruce Carlson will present highlights from the reports finding including general trends in IVD, drivers and inhibitors, and some segmented and regional results.
Procedure Volumes are estimates of how many times test procedures are employed on a yearly basis globally and in various regions, across segments of testing. They are essential building blocks of business planning and indicators of market opportunities.
Specific areas of focus include clinical chemistry, infectious disease, oncology and point of care testing.